KRW
TXG icon

Kaufman Rossin Wealth’s 10x Genomics TXG Stock Holding History

Kaufman Rossin Wealth’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$293K Buy
+6,799
New +$178K 0.14% 76

Other funds holding TXG

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Kaufman Rossin Wealth's TXG Position: Q2 2026 in Review

Kaufman Rossin Wealth opened a new position in 10x Genomics (TXG) in Q2 2026: 6,799 shares worth $293K. The stake represents 0.14% of the portfolio and ranks #76 among its holdings.

60 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Kaufman Rossin Wealth held 6,799 shares of 10x Genomics worth $293K as of Q2 2026.
  • 10x Genomics was a new Kaufman Rossin Wealth position in Q2 2026.
  • 10x Genomics made up 0.14% of Kaufman Rossin Wealth's portfolio in Q2 2026, its #76 holding.
  • 60 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Kaufman Rossin Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.